VWF and ADAMTS13 behavior in estradiol-treated HUVEC.
Eur J Haematol
; 86(2): 140-7, 2011 Feb.
Article
em En
| MEDLINE
| ID: mdl-20958794
ABSTRACT
OBJECTIVES:
In this study, the role of 17ß-estradiol (E2) in the regulation of von Willebrand factor (VWF) and ADAMTS13 synthesis, storage, and secretion was investigated in cultured human umbilical vein endothelial cells (HUVEC).METHODS:
HUVEC were grown to 80-90% confluence and replaced with fresh medium containing E2 (1 nm) or vehicle for 24 h, after which the supernatant medium and cell lysates were collected to measure VWF and ADAMTS13. VWF was evaluated by VWFAg and multimeric analysis. ADAMTS13 was evaluated by SDS-PAGE. VWF and ADAMTS13 mRNA were quantified by real-time PCR after E2 or vehicle exposure for 18 h. A functional effect of ADAMTS13 on HUVEC VWF protein synthesis was further evaluated using a short hairpin RNA (shRNA) to knockdown the expression of endogenous ADAMTS13.RESULTS:
E2 did not increase the release or intracellular VWF levels in HUVEC. However, E2 increased the production of intracellular ADAMTS13, although there was no evidence of significant effects of their release into culture medium. Incubation of HUVEC with E2 resulted in a significantly increased expression of VWF and ADAMTS13 mRNA. ADAMTS13 gene inactivation upregulates release and intracellular VWF levels in E2-treated HUVEC.CONCLUSION:
The results demonstrated that E2 may play a role in the regulation of VWF and ADAMTS13 gene expression and in its production in human endothelial cells. The mechanism of the protective effects of E2 on the cardiovascular system could be explained by the intracellular regulation of VWF produced by ADAMTS13.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fator de von Willebrand
/
Regulação da Expressão Gênica
/
Células Endoteliais
/
Estradiol
/
Proteínas ADAM
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article